Related Experiment Video
Updated: Nov 27, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Impact of interventional and non-interventional variables on anthropometric long-term development in glutaric
E M Charlotte Märtner1, Esther M Maier2, Katharina Mengler1
1Division of Child Neurology and Metabolic Medicine, Centre for Child and Adolescent Medicine, University Hospital Heidelberg, Germany.
Insights
Early diagnosis of Glutaric aciduria type 1 (GA1) via newborn screening and adherence to emergency treatment (ET) ensure normal growth. Non-adherence and dystonia negatively impact weight and length in GA1 patients.
Area of Science:
- Neurology
- Metabolic Disorders
- Genetics
Background:
- Glutaric aciduria type 1 (GA1) is a rare neurometabolic disorder caused by glutaryl-CoA dehydrogenase deficiency, primarily impacting the brain.
- Newborn screening (NBS) is crucial for early identification and improved neurological outcomes in GA1 patients.
Purpose of the Study:
- To investigate the long-term anthropometric and neurological effects of recommended therapy, including diet and emergency treatment (ET), in GA1 patients identified by NBS.
- To assess the impact of adherence to treatment protocols on growth parameters (weight, length, BMI, head circumference) and neurological development.
Main Methods:
- A national prospective, observational, multi-centre study involving 79 GA1 patients identified via NBS.
- Analysis of interventional and non-interventional parameters, including adherence to maintenance and emergency treatment, and their correlation with anthropometric and neurological outcomes.
- Longitudinal analysis to track developmental trajectories over time.
Main Results:
- Adherence to recommended maintenance and emergency treatment positively influenced neurological outcomes and supported normal anthropometric development into adulthood.
- Non-adherence to ET was associated with a higher risk of dystonia and negatively impacted body weight (mean SDS -1.07) and length (mean SDS -1.34).
- Severe dystonia negatively affected weight and length development over time (P < .001). Macrocephaly was more prevalent in females and high excreter phenotypes.
Conclusions:
- Recommended long-term treatment for GA1 is effective in achieving normal anthropometric development up to adolescence, with variations based on gender and excreter type.
- Delayed emergency treatment and severe movement disorders like dystonia are linked to poor anthropometric outcomes in GA1.
- Early identification through NBS and consistent adherence to treatment protocols are vital for optimizing both neurological and growth outcomes in GA1.
Abstract:
Glutaric aciduria type 1 (GA1) is a rare neurometabolic disorder, caused by inherited deficiency of glutaryl-CoA dehydrogenase, mostly affecting the brain. Early identification by newborn screening (NBS) significantly improves neurologic outcome. It has remained unclear whether recommended therapy, particular low lysine diet, is safe or negatively affects anthropometric long-term outcome. This national prospective, observational, multi-centre study included 79 patients identified by NBS and investigated effects of interventional and non-interventional parameters on body weight, body length, body mass index (BMI) and head circumference as well as neurological parameters. Adherence to recommended maintenance and emergency treatment (ET) had a positive impact on neurologic outcome and allowed normal anthropometric development until adulthood. In contrast, non-adherence to ET, resulting in increased risk of dystonia, had a negative impact on body weight (mean SDS -1.07; P = .023) and body length (mean SDS -1.34; P = -.016). Consistently, longitudinal analysis showed a negative influence of severe dystonia on weight and length development over time (P < .001). Macrocephaly was more often found in female (mean SDS 0.56) than in male patients (mean SDS -0.20; P = .049), and also in individuals with high excreter phenotype (mean SDS 0.44) compared to low excreter patients (mean SDS -0.68; P = .016). In GA1, recommended long-term treatment is effective and allows for normal anthropometric long-term development up to adolescence, with gender- and excreter type-specific variations. Delayed ET and severe movement disorder result in poor anthropometric outcome.
More Related Videos
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Bioavailability Study Design: Healthy Subjects Versus Patients